The role of positron emission tomography in different types of malignant lymphomas: the results of 2020

The review presents the results of studies published in 2020 concerning the role of positron emission tomography (PET) in the diagnosis of different types of malignant lymphomas. The authors tried to highlight the current trends in the development of the PET method in case of Hodgkin lymphoma, diffu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladislav O. Sarzhevskiy, Olga V. Mukhortova
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
Acceso en línea:https://doaj.org/article/7e80f0465c6349b89bc19f4c9659c4c0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7e80f0465c6349b89bc19f4c9659c4c0
record_format dspace
spelling oai:doaj.org-article:7e80f0465c6349b89bc19f4c9659c4c02021-11-30T16:55:01ZThe role of positron emission tomography in different types of malignant lymphomas: the results of 20201815-14341815-144210.26442/18151434.2021.1.200745https://doaj.org/article/7e80f0465c6349b89bc19f4c9659c4c02021-05-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/70512/51427https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442The review presents the results of studies published in 2020 concerning the role of positron emission tomography (PET) in the diagnosis of different types of malignant lymphomas. The authors tried to highlight the current trends in the development of the PET method in case of Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma and multiple myeloma. The topic concerning the use of PET in immunotherapy is highlighted separately. There was also an emphasis on the interpretation of quantitative imaging biomarkers used in PET. The concept of PET-adapted approach in Hodgkin lymphoma, the predictive significance of PET before high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma, predictive value of intermediate PET in case of follicular lymphoma, the application of methionine as PET tracer to diagnose tumor burden and to measure minimal residual disease in case of multiple myeloma, the variants of atypical tumor response to the immune checkpoint inhibitors therapy, PET in diagnosing immune-mediated adverse events are currently relevant for oncologists, hematologists, radiologists and discussed in this article. In the context of the topics the authors showed the results of PET imaging of Russian patients who had PET examination in the Bakulev National Medical Research Center for Cardiovascular Surgery.Vladislav O. SarzhevskiyOlga V. MukhortovaIP Habib O.N.articlemalignant lymphomaspositron emission tomographyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 23, Iss 1, Pp 192-200 (2021)
institution DOAJ
collection DOAJ
language RU
topic malignant lymphomas
positron emission tomography
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle malignant lymphomas
positron emission tomography
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Vladislav O. Sarzhevskiy
Olga V. Mukhortova
The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
description The review presents the results of studies published in 2020 concerning the role of positron emission tomography (PET) in the diagnosis of different types of malignant lymphomas. The authors tried to highlight the current trends in the development of the PET method in case of Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma and multiple myeloma. The topic concerning the use of PET in immunotherapy is highlighted separately. There was also an emphasis on the interpretation of quantitative imaging biomarkers used in PET. The concept of PET-adapted approach in Hodgkin lymphoma, the predictive significance of PET before high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma, predictive value of intermediate PET in case of follicular lymphoma, the application of methionine as PET tracer to diagnose tumor burden and to measure minimal residual disease in case of multiple myeloma, the variants of atypical tumor response to the immune checkpoint inhibitors therapy, PET in diagnosing immune-mediated adverse events are currently relevant for oncologists, hematologists, radiologists and discussed in this article. In the context of the topics the authors showed the results of PET imaging of Russian patients who had PET examination in the Bakulev National Medical Research Center for Cardiovascular Surgery.
format article
author Vladislav O. Sarzhevskiy
Olga V. Mukhortova
author_facet Vladislav O. Sarzhevskiy
Olga V. Mukhortova
author_sort Vladislav O. Sarzhevskiy
title The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
title_short The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
title_full The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
title_fullStr The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
title_full_unstemmed The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
title_sort role of positron emission tomography in different types of malignant lymphomas: the results of 2020
publisher IP Habib O.N.
publishDate 2021
url https://doaj.org/article/7e80f0465c6349b89bc19f4c9659c4c0
work_keys_str_mv AT vladislavosarzhevskiy theroleofpositronemissiontomographyindifferenttypesofmalignantlymphomastheresultsof2020
AT olgavmukhortova theroleofpositronemissiontomographyindifferenttypesofmalignantlymphomastheresultsof2020
AT vladislavosarzhevskiy roleofpositronemissiontomographyindifferenttypesofmalignantlymphomastheresultsof2020
AT olgavmukhortova roleofpositronemissiontomographyindifferenttypesofmalignantlymphomastheresultsof2020
_version_ 1718406453758263296